Overlevelse hos voksne med akutt lymfoblastisk leukemi

Tidsskrift for den Norske Laegeforening

Volumn 130, Issue 17, 2010, Pages 1710-

  Tangen, Jon Magnus ^a   Fløisand, Yngvar ^b   Haukås, Einar ^c   Anne Næss, Inger ^d   Skjelbakken, Tove ^c   Stapnes, Camilla ^e   Tjønnfjord, Geir E ^b,f  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Stavanger universitetssjukehus ^*  (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; HUMAN; MIDDLE AGED; MORTALITY; NORWAY; PROGNOSIS; REGISTER; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; MIDDLE AGED; NORWAY; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; REGISTRIES; SURVIVAL RATE; YOUNG ADULT;

EID: 78149364846     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.09.1293     Document Type: Article

References (18)

1. Borowitz MJ, Chan JKC. Precursor lymphoid neoplasms. I: Swerdlow SH, Campo E, Harris NL et al, red. WHO classification of tumors of haematopoietic and lymphoid tissues. 4. utg. Lyon: IARC,.2008.
2. Brinch L. Akutte leukemier og myelodysplastiske syndromer. I: Evensen SA, Brinch L, Tjønnfjord GE et al, red. Blodsykdommer. Oslo: Gyldendal Akademisk, 2008: 127-652.
3. Pui CH, Robinson LI, Look AT. Acute lymphoblastic leukaemia. Lancet 2008; 371: 1030-43.
4. Phui CH, Evans WE. Treatment of acute lymphoblastic leukaemia. N Engl J Med 2006; 354: 782-5.
5. Styczynski J, Pietrs R, Huismans DR et al. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia. Br J Haematol 2000; 110: 813-8.
6. Evensen SA, Brinch L, Tjønnfjord G et al. Estimated 8-year survival of more than 40 % in a populationbased study of 79 adult patients with acute lymphoblastic leukaemia. Br J Haematol 1994; 88: 88-93.
7. Thomas X, Boiron JM, Huguet F et al. Outcome of treatment of adults with acute lymphoblastic leukemia. Analysis of the LALA-94 trial. J Clin Oncol 2004; 22: 4075-86.
8. Hammerstrøm J, Ernst P, Lauritzen GF et al. Handlingsprogram for diagnostikk og behandling av akutt lymfoblastisk leukemi/lymfoblastisk lymfom og Burkitt leukemi/lymfom hos voksne. www.legeforeningen.no/asset/33493/1/33493_1.doc (6.5.2008).
9. Bene MC, Castoldi G, Knapp W et al. Proposals for the immunological classification of acute leukemias: European Group for the Immunological classification of Leukemias (EGIL). Leukemia 1955; 9: 1783-6.
10. Tjønnfjord GE, Gedde-Dahl T, Heldal D et.al. Treatment outcome in adults with acute lymphoblastic leukemia: 50 % long term disease-free survival. Leukemia 2007; 10: 2203-4.
11. Annino L, Vegna ML, Camera A et al. Treatment of adult acute lymphoblastic leukemia(ALL). Long term term follow-up of the GIMEMA ALL 0288 randomized study. Blood 2002; 99: 863-71.
12. Rowe JM, Buck G, Burnett AK. Induction therapy for adults with acute lymphoblastic leukaemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood 2005; 106: 3760-7.
13. Gökbuget N, Arnold R, Buechner Th et al. Intensification of induction and consolidation improves only subgroups of adult ALL: analysis of 1200 patients in the GMALL study 05/93 (abstract). Blood 2001; 98: 802a.
14. Fløisand Y, Brinch L, Dybedal I et al. Allogen stamcelletransplantasjon hos voksne med akutt lymfoblastisk leukemi. Tidsskr Nor Legeforen 2008; 108: 2563-6.
15. Boissel N, Auclerc M-F, Lhéritier V et al. Should adolescents with acute lymphoblasic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2003; 21: 774-80.
16. Haiat S, Vekhoff A, Marzac C et al. Improved outcome of adults with acute lymphoblastic leukaemia treated with a pediatrc protocol: results of a pilot study. Blood (ASH) Annual Meeting Abstracts) 2007; 110: 2822a.
17. de Bont JM, van der Holt B, Dekker W et al. Significant differences in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs. adult protocols in the Netherlands. Leukemia 2004; 18: 2032-5.
18. Nordisk forening for pediatrisk hematologi og onkologi. www.nopho.org (20.7.210).